Buy or sell Codiak Biosciences stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Codiak Biosciences Stock

Biotechnology

Founded

2015

Notable Investors

Flagship Pioneering

Headquarters

San Francisco CA, US

Total Funding

$174M

About Codiak Biosciences Stock

Codiak Biosciences is developing exosomes, natural vesicles that mediate inter-cellular communication, as both a powerful therapeutic modality and an advanced diagnostic system. Codiak is building a world-class team and has generated and acquired foundational intellectual property that will allow it to capitalize on the unique potential of exosome biology.

Investors

Funding History

November 2015$33.2M
November 2015$64.2M
November 2017$76.5M

Management

President and CEO

Doug Williams

CBO

Richard Brudnick

CFO

Linda C. Bain

Press

Other Companies

Logo
Atomwise

Atomwise develops artificial intelligence systems using powerful deep learning algorithms and supercomputers for drug discovery.

Logo
Beam Therapeutics

Developer of genome editing technologies.

Logo
Equian

Equian is a healthcare information services company focused on lowering the cost of care by eliminating waste.

Logo
Onko Solutions

Onko is committed to the development and commercialization of solutions that contribute to the detection, and prevention of cervical cancer.

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Codiak Biosciences or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 70K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo

Logo